The Variants in ADIPOQ are Associated with Maternal Circulating Adipokine Profile in Gestational Diabetes Mellitus

References

• Ogurtsova K, da Rocha Fernandes JD, Huang Y, et al. IDF diabetes atlas: global estimates for the prevalence of diabetes for 2015 and 2040. Diabetes Res Clin Pract. 2017;128:40–50. doi:10.1016/j.diabres.2017.03.024
   PubMed Web of Science ®Google Scholar
• Farrar D. Hyperglycemia in pregnancy: prevalence, impact, and management challenges. Int J Womens Health. 2016;8:519–527. doi:10.2147/IJWH.S102117
   PubMed Web of Science ®Google Scholar
• Alejandro EU, Mamerto TP, Chung G, et al. Gestational diabetes mellitus: a harbinger of the vicious cycle of diabetes. Int J Mol Sci. 2020;21:14. doi:10.3390/ijms21145003
   Web of Science ®Google Scholar
• Moyce BL, Dolinsky VW. Maternal β-cell adaptations in pregnancy and placental signalling: implications for gestational diabetes. Int J Mol Sci. 2018;19:11. doi:10.3390/ijms19113467
   Web of Science ®Google Scholar
• American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2013;37(Supplement_1):S81–S90. doi:10.2337/dc14-S081
   PubMedGoogle Scholar
• Ornoy A, Becker M, Weinstein-Fudim L, Ergaz Z. Diabetes during pregnancy: a maternal disease complicating the course of pregnancy with long-term deleterious effects on the offspring. A clinical review. Int J Mol Sci. 2021;22:6. doi:10.3390/ijms22062965
   Web of Science ®Google Scholar
• Gutaj P, Sibiak R, Jankowski M, et al. The role of the adipokines in the most common gestational complications. Int J Mol Sci. 2020;21:24. doi:10.3390/ijms21249408
   Web of Science ®Google Scholar
• Dilworth L, Facey A, Omoruyi F. Diabetes mellitus and its metabolic complications: the role of adipose tissues. Int J Mol Sci. 2021;22:14. doi:10.3390/ijms22147644
   Google Scholar
• Kampmann U, Knorr S, Fuglsang J, Ovesen P. Determinants of maternal insulin resistance during pregnancy: an updated overview. J Diabetes Res. 2019;2019:5320156. doi:10.1155/2019/5320156
   PubMed Web of Science ®Google Scholar
• Garg MK, Dutta MK, Mahalle N. Adipokines (adiponectin and plasminogen activator inhibitor-1) in metabolic syndrome. Indian J Endocrinol Metab. 2012;16(1):116–123. doi:10.4103/2230-8210.91206
   PubMedGoogle Scholar
• Ellulu MS, Patimah I, Khaza’ai H, Rahmat A, Abed Y. Obesity and inflammation: the linking mechanism and the complications. Arch Med Sci. 2017;13(4):851–863. doi:10.5114/aoms.2016.58928
   PubMed Web of Science ®Google Scholar
• Esfahani M, Movahedian A, Baranchi M, Goodarzi MT. Adiponectin: an adipokine with protective features against metabolic syndrome. Iran J Basic Med Sci. 2015;18(5):430–442.
   PubMed Web of Science ®Google Scholar
• Hedderson MM, Darbinian J, Havel PJ, et al. Low prepregnancy adiponectin concentrations are associated with a marked increase in risk for development of gestational diabetes mellitus. Diabetes Care. 2013;36(12):3930–3937. doi:10.2337/dc13-0389
   PubMed Web of Science ®Google Scholar
• Howlader M, Sultana MI, Akter F, Hossain MM. Adiponectin gene polymorphisms associated with diabetes mellitus: a descriptive review. Heliyon. 2021;7(8):e07851. doi:10.1016/j.heliyon.2021.e07851
   PubMed Web of Science ®Google Scholar
• Pawlik A, Teler J, Maciejewska A, Sawczuk M, Safranow K, Dziedziejko V. Adiponectin and leptin gene polymorphisms in women with gestational diabetes mellitus. J Assist Reprod Genet. 2017;34(4):511–516. doi:10.1007/s10815-016-0866-2
   PubMed Web of Science ®Google Scholar
• Low CF, Mohd Tohit ER, Chong PP, Idris F. Adiponectin SNP45TG is associated with gestational diabetes mellitus. Arch Gynecol Obstet. 2011;283(6):1255–1260. doi:10.1007/s00404-010-1548-4
   PubMed Web of Science ®Google Scholar
• Kouhkan A, Najafi L, Malek M, et al. Gestational diabetes mellitus: major risk factors and pregnancy-related outcomes: a cohort study. Int J Reprod Biomed. 2021;19(9):827–836. doi:10.18502/ijrm.v19i9.9715
   PubMed Web of Science ®Google Scholar
• Miao M, Dai M, Zhang Y, Sun F, Guo X, Sun G. Influence of maternal overweight, obesity and gestational weight gain on the perinatal outcomes in women with gestational diabetes mellitus. Sci Rep. 2017;7(1):305. doi:10.1038/s41598-017-00441-z
   PubMedGoogle Scholar
• Tumurbaatar B, Poole AT, Olson G, et al. Adipose tissue insulin resistance in gestational diabetes. Metab Syndr Relat Disord. 2017;15(2):86–92. doi:10.1089/met.2016.0124
   PubMed Web of Science ®Google Scholar
• Guelfi KJ, Ong MJ, Li S, et al. Maternal circulating adipokine profile and insulin resistance in women at high risk of developing gestational diabetes mellitus. Metabolism. 2017;75:54–60. doi:10.1016/j.metabol.2017.08.003
   PubMed Web of Science ®Google Scholar
• Xue A, Wu Y, Zhu Z, et al. Genome-wide association analyses identify 143 risk variants and putative regulatory mechanisms for type 2 diabetes. Nat Commun. 2018;9(1):2941. doi:10.1038/s41467-018-04951-w
   PubMed Web of Science ®Google Scholar
• Meller M, Qiu C, Vadachkoria S, Abetew DF, Luthy DA, Williams MA. Changes in placental adipocytokine gene expression associated with gestational diabetes mellitus. Physiol Res. 2006;55(5):501–512. doi:10.33549/physiolres.930830
   PubMed Web of Science ®Google Scholar
• Pala HG, Ozalp Y, Yener AS, Gerceklioglu G, Uysal S, Onvural A. Adiponectin levels in gestational diabetes mellitus and in pregnant women without glucose intolerance. Adv Clin Exp Med. 2015;24(1):85–92. doi:10.17219/acem/38141
   PubMed Web of Science ®Google Scholar
• Wang P, Keijer J, Bunschoten A, Bouwman F, Renes J, Mariman E. Insulin modulates the secretion of proteins from mature 3T3-L1 adipocytes: a role for transcriptional regulation of processing. Diabetologia. 2006;49(10):2453–2462. doi:10.1007/s00125-006-0321-5
   PubMed Web of Science ®Google Scholar
• Lo JC, Ljubicic S, Leibiger B, et al. Adipsin is an adipokine that improves β cell function in diabetes. Cell. 2014;158(1):41–53. doi:10.1016/j.cell.2014.06.005
   PubMed Web of Science ®Google Scholar
• Vitoratos N, Deliveliotou A, Dimitrakaki A, et al. Maternal serum resistin concentrations in gestational diabetes mellitus and normal pregnancies. J Obstet Gynaecol Res. 2011;37(2):112–118. doi:10.1111/j.1447-0756.2010.01327.x
   PubMed Web of Science ®Google Scholar
• Megia A, Vendrell J, Gutierrez C, et al. Insulin sensitivity and resistin levels in gestational diabetes mellitus and after parturition. Eur J Endocrinol. 2008;158(2):173–178. doi:10.1530/EJE-07-0671
   PubMed Web of Science ®Google Scholar
• Lou Y, Wu C, Wu M, Xie C, Ren L. The changes of neutrophil gelatinase-associated lipocalin in plasma and its expression in adipose tissue in pregnant women with gestational diabetes. Diabetes Res Clin Pract. 2014;104(1):136–142. doi:10.1016/j.diabres.2014.01.014
   PubMed Web of Science ®Google Scholar
• Cesari M, Pahor M, Incalzi RA. Plasminogen activator inhibitor-1 (PAI-1): a key factor linking fibrinolysis and age-related subclinical and clinical conditions. Cardiovasc Ther. 2010;28(5):e72–91. doi:10.1111/j.1755-5922.2010.00171.x
   PubMed Web of Science ®Google Scholar
• Nawaz SS, Siddiqui K. Plasminogen activator inhibitor-1 mediate downregulation of adiponectin in type 2 diabetes patients with metabolic syndrome. Cytokine X. 2022;4(1):100064. doi:10.1016/j.cytox.2022.100064
   PubMedGoogle Scholar
• Lacroix M, Battista MC, Doyon M, et al. Lower adiponectin levels at first trimester of pregnancy are associated with increased insulin resistance and higher risk of developing gestational diabetes mellitus. Diabetes Care. 2013;36(6):1577–1583. doi:10.2337/dc12-1731
   PubMed Web of Science ®Google Scholar
• Mallardo M, Ferraro S, Daniele A, Nigro E. GDM-complicated pregnancies: focus on adipokines. Mol Biol Rep. 2021;48(12):8171–8180. doi:10.1007/s11033-021-06785-0
   PubMed Web of Science ®Google Scholar
• Doruk M, Uğur M, Oruç AS, Demirel N, Yildiz Y. Serum adiponectin in gestational diabetes and its relation to pregnancy outcome. J Obstet Gynaecol. 2014;34(6):471–475. doi:10.3109/01443615.2014.902430
   PubMedGoogle Scholar
• Han Y, Zheng YL, Fan YP, Liu MH, Lu XY, Tao Q. Association of adiponectin gene polymorphism 45TG with gestational diabetes mellitus diagnosed on the new IADPSG criteria, plasma adiponectin levels and adverse pregnancy outcomes. Clin Exp Med. 2015;15(1):47–53. doi:10.1007/s10238-014-0275-8
   PubMed Web of Science ®Google Scholar
• Choi J-H, Min NY, Park SK, et al. Dual matrilineal geographic distribution of Korean type 2 diabetes mellitus-associated −11377 G adiponectin allele. Mol Med Rep. 2014;10(6):2993–3002. doi:10.3892/mmr.2014.2639
   PubMed Web of Science ®Google Scholar
• Nomani H, Hesami O, Vaisi-Raygani A, et al. Association between the −11377 C/G and −11391 G/A polymorphisms of adiponectin gene and adiponectin levels with susceptibility to type 1 and type 2 diabetes mellitus in population from the west of Iran, correlation with lipid profile. J Cell Biochem. 2019;120(3):3574–3582. doi:10.1002/jcb.27634
   PubMed Web of Science ®Google Scholar
• Huang LT, Wu SL, Liao X, Ma SJ, Tan HZ. Adiponectin gene polymorphisms and risk of gestational diabetes mellitus: a meta-analysis. World J Clin Cases. 2019;7(5):572–584. doi:10.12998/wjcc.v7.i5.572
   PubMed Web of Science ®Google Scholar
• de Luis DA, Izaola O, Primo D, et al. Role of rs1501299 variant in the adiponectin gene on total adiponectin levels, insulin resistance and weight loss after a Mediterranean hypocaloric diet. Diabetes Res Clin Pract. 2019;148:262–267. doi:10.1016/j.diabres.2017.11.007
   PubMed Web of Science ®Google Scholar